GH Guardant Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GH

Price (delayed)

$17.65

Market cap

$2.15B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.28

Enterprise value

$2.34B

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health ...

Highlights
Guardant Health's revenue has increased by 25% YoY and by 5% from the previous quarter
The gross profit has grown by 15% YoY and by 3.9% from the previous quarter
GH's equity has soared by 164% YoY but it is down by 30% QoQ
The EPS is up by 33% year-on-year but it has declined by 5% since the previous quarter
Guardant Health's gross margin has decreased by 8% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.guardanthealth.com
Peers: NEOG NTRA MYGN

Key stats

What are the main financial stats of GH
Market
Shares outstanding
121.71M
Market cap
$2.15B
Enterprise value
$2.34B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.12
Price to sales (P/S)
3.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.15
Earnings
Revenue
$563.95M
EBIT
-$476.19M
EBITDA
-$433.31M
Free cash flow
-$345.46M
Per share
EPS
-$4.28
Free cash flow per share
-$3.08
Book value per share
$1.34
Revenue per share
$5.04
TBVPS
$15.84
Balance sheet
Total assets
$1.79B
Total liabilities
$1.63B
Debt
$1.33B
Equity
$158.68M
Working capital
$1.14B
Liquidity
Debt to equity
8.36
Current ratio
6.54
Quick ratio
6.11
Net debt/EBITDA
-0.44
Margins
EBITDA margin
-76.8%
Gross margin
59.7%
Net margin
-85%
Operating margin
-100.1%
Efficiency
Return on assets
-27.7%
Return on equity
-301.9%
Return on invested capital
-20.5%
Return on capital employed
-30.1%
Return on sales
-84.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GH stock price

How has the Guardant Health stock price performed over time
Intraday
0.34%
1 week
9.22%
1 month
2.32%
1 year
-27.99%
YTD
-34.75%
QTD
-14.44%

Financial performance

How have Guardant Health's revenue and profit performed over time
Revenue
$563.95M
Gross profit
$336.9M
Operating income
-$564.73M
Net income
-$479.45M
Gross margin
59.7%
Net margin
-85%
The net margin is up by 42% year-on-year but it has declined by 5% since the previous quarter
Guardant Health's net income has increased by 27% YoY but it has decreased by 11% QoQ
Guardant Health's revenue has increased by 25% YoY and by 5% from the previous quarter
The company's operating margin rose by 17% YoY but it fell by 4.5% QoQ

Growth

What is Guardant Health's growth rate over time

Valuation

What is Guardant Health stock price valuation
P/E
N/A
P/B
13.12
P/S
3.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.15
The EPS is up by 33% year-on-year but it has declined by 5% since the previous quarter
GH's equity has soared by 164% YoY but it is down by 30% QoQ
The P/B is 16% less than the 5-year quarterly average of 15.6
The P/S is 86% below the 5-year quarterly average of 25.6 and 43% below the last 4 quarters average of 6.1
Guardant Health's revenue has increased by 25% YoY and by 5% from the previous quarter

Efficiency

How efficient is Guardant Health business performance
The return on sales is up by 42% year-on-year but it has declined by 6% since the previous quarter
The ROE has contracted by 24% YoY but it has grown by 6% from the previous quarter
GH's ROA is up by 23% year-on-year but it is down by 8% since the previous quarter
Guardant Health's ROIC has decreased by 21% from the previous quarter but it has increased by 15% YoY

Dividends

What is GH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GH.

Financial health

How did Guardant Health financials performed over time
Guardant Health's total assets is 10% more than its total liabilities
Guardant Health's quick ratio has increased by 11% from the previous quarter and by 6% YoY
Guardant Health's total assets has increased by 11% YoY
GH's equity has soared by 164% YoY but it is down by 30% QoQ
GH's debt to equity has dropped by 63% year-on-year but it is up by 43% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.